NutraCea Granted Patent on Proprietary Formula for Joint Health

NutraCea Granted Patent on Proprietary Formula for Joint Health Company receives U.S. Patent Number 6,902,739, from the United States Patent and Trademark Office entitled, Methods for Treating Joint Inflammation, Pain and Loss of Mobility.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Glucosamine HCI Application Under Discussion Glucosamine HCI Application Under Discussion Cargill Acidulants Expands its REGENASURE(TM) Glucosamine Marketing Efforts to Japan Cargill Acidulants Expands its REGENASURE(TM) Glucosamine Marketing Efforts to Japan Cargill Acidulants Expands its REGENASURE(TM) Glucosamine Marketing Efforts to Japan Cargill Acidulants Expands its REGENASURE(TM) Glucosamine Marketing Efforts to Japan Proprietary Nutritionals Attains Marketing Rights for Celadrin Joint Health Ingredient PNI to market the product worldwide, with the exception of India and China. Proprietary Nutritionals Attains Marketing Rights for Celadrin Joint Health Ingredient PNI to market the product worldwide, with the exception of India and China. Proprietary Nutritionals Attains Marketing Rights for Celadrin Joint Health Ingredient PNI to market the product worldwide, with the exception of India and China. Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Cargill’s REGENASURE® Glucosamine is Approved for Use in the United Kingdom Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. AOAC Officially Approves NOW Foods’ Glucosamine HPLC Method as a First Action Official Method(SM) AOAC Methods Committee on Dietary Supplements have voted to approve NOW’s method, Determination of Glucosamine in Raw Materials and Dietary Supplements Containing Glucosamine Sulfate and/or Glucosamine Hydrochloride by HPLC with FMOC-Su Derivatization as an AOAC First Action Official Method(SM). AOAC Officially Approves NOW Foods’ Glucosamine HPLC Method as a First Action Official Method(SM) AOAC Methods Committee on Dietary Supplements have voted to approve NOW’s method, Determination of Glucosamine in Raw Materials and Dietary Supplements Containing Glucosamine Sulfate and/or Glucosamine Hydrochloride by HPLC with FMOC-Su Derivatization as an AOAC First Action Official Method(SM). AOAC Officially Approves NOW Foods’ Glucosamine HPLC Method as a First Action Official Method(SM) AOAC Methods Committee on Dietary Supplements have voted to approve NOW’s method, Determination of Glucosamine in Raw Materials and Dietary Supplements Containing Glucosamine Sulfate and/or Glucosamine Hydrochloride by HPLC with FMOC-Su Derivatization as an AOAC First Action Official Method(SM). AOAC Officially Approves NOW Foods’ Glucosamine HPLC Method as a First Action Official Method(SM) AOAC Methods Committee on Dietary Supplements have voted to approve NOW’s method, Determination of Glucosamine in Raw Materials and Dietary Supplements Containing Glucosamine Sulfate and/or Glucosamine Hydrochloride by HPLC with FMOC-Su Derivatization as an AOAC First Action Official Method(SM). AOAC Officially Approves NOW Foods’ Glucosamine HPLC Method as a First Action Official Method(SM) AOAC Methods Committee on Dietary Supplements have voted to approve NOW’s method, Determination of Glucosamine in Raw Materials and Dietary Supplements Containing Glucosamine Sulfate and/or Glucosamine Hydrochloride by HPLC with FMOC-Su Derivatization as an AOAC First Action Official Method(SM). SourceOne Extends Exclusive Chondroitin Sulfate Supply Agreement company has announced that it has extended its agreement with Yantai Kangde Biochemical Products Co., Ltd., (Kangde) to exclusively distribute Kangde’s bovine chondroitin sulfate. SourceOne Extends Exclusive Chondroitin Sulfate Supply Agreement company has announced that it has extended its agreement with Yantai Kangde Biochemical Products Co., Ltd., (Kangde) to exclusively distribute Kangde’s bovine chondroitin sulfate. SourceOne Extends Exclusive Chondroitin Sulfate Supply Agreement company has announced that it has extended its agreement with Yantai Kangde Biochemical Products Co., Ltd., (Kangde) to exclusively distribute Kangde’s bovine chondroitin sulfate. SourceOne Extends Exclusive Chondroitin Sulfate Supply Agreement company has announced that it has extended its agreement with Yantai Kangde Biochemical Products Co., Ltd., (Kangde) to exclusively distribute Kangde’s bovine chondroitin sulfate. SourceOne Extends Exclusive Chondroitin Sulfate Supply Agreement company has announced that it has extended its agreement with Yantai Kangde Biochemical Products Co., Ltd., (Kangde) to exclusively distribute Kangde’s bovine chondroitin sulfate. Mineral Miracle, written by Drs. Shari Lieberman and Alan Xenakis Mineral Miracle, written by authors Drs. Shari Lieberman and Alan Xenakis, introduces a natural mineral complex, including how it was discovered and how it works. Mineral Miracle, written by Drs. Shari Lieberman and Alan Xenakis Mineral Miracle, written by authors Drs. Shari Lieberman and Alan Xenakis, introduces a natural mineral complex, including how it was discovered and how it works. Mineral Miracle, written by Drs. Shari Lieberman and Alan Xenakis Mineral Miracle, written by authors Drs. Shari Lieberman and Alan Xenakis, introduces a natural mineral complex, including how it was discovered and how it works. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise. Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Arthritis Breakthrough that Activates the Gene Responsible for Regenerating Cartilage Enters Clinical Trials The clinical study being conducted by clinical research organization Santerra Pharmaceuticals, LLC was submitted to Current Controlled Trials for review of the protocol and assignment of an International Standardized Randomized Controlled Trial Number (ISRCTN25438351). Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Webcast : Joint Pain & Profits: What’s driving the Joint Health Category Webcast, Sponsored By Bergstrom Nutrition, to be held Tuesday, November 7, 2006, at 2:00 PM Eastern /11:00 AM Pacific. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	EL DORADO HILLS, Calif., June 8, 2005 /PRNewswire-FirstCall via COMTEX/ -- NutraCea announced today that they have been issued a new patent, U.S. Patent Number 6,902,739, from the United States Patent and Trademark Office entitled, Methods for Treating Joint Inflammation, Pain and Loss of Mobility. The patent contains 14 claims, which include a method for treating lameness, pain and loss of mobility in humans and mammals and a method for inhibiting prostaglandin synthetase activity, which is also known as COX-2 inhibition. According to the Company, the new patent supports NutraCea's strategy of aggressive expansion of its intellectual property portfolio with proprietary technology based solutions that offer unique partnership and licensing opportunities across several multi-billion dollar segments for food, pharmaceutical and specialty healthcare companies. "As Chairman of NutraCea's Medical Advisory Board, we're really pleased to have this patent issued, especially at a time when safe choices for treatment of arthritic pain and inflammation are being challenged with the recall of several pharmaceutical drugs," said Dr. Eliot Drell. "Additionally, this patent is not limited in its application for humans but is extended to include all equine and other mammals as well. We feel it will be a positive step and add additional impetus for our existing product supply relationship with our equine provider; W.F. Young Company is a 113- year-old family-owned company, a leading developer and marketer of health, beauty and grooming products for the equine industry and external analgesics for the human healthcare market sold under the brand name of Absorbine Junior," commented McPeak. About NutraCea(R) NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a waste by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," and all-natural "cosmeceutical" beauty aids. More information can be found in the company's filings with the SEC. and you can visit the NutraCea web site http://www.NutraCea.com. This release contains statements that are forward looking. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software

This article has been moved here